本文へ移動
cccskills
無料GitHub で公開

es-cushing-additional-treatments-persistent-hypercortisolism

Recommends additional treatments for patients with persistent overt hypercortisolism after initial surgical intervention for Cushing's syndrome. Trigger phrases include "post-op CS patient shows ongoing hypercortisolism," "persistent overt hypercortisolism after TSS," and "elevated UFC or midnight salivary cortisol following surgery."

dromlakhani/MD2SKILL
インストール方法を見る

含まれるファイル（1）

  • SKILL.md3.1 KB

SKILL.md（原文）

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Additional Treatments for Persistent Overt Hypercortisolism in Cushing's Syndrome

STEP 1 — Gather Information

Collect postoperative biochemical tests (24‑h UFC, midnight salivary cortisol, morning serum cortisol) obtained 1–3 months after transsphenoidal surgery; document clinical signs/symptoms of hypercortisolism (weight gain, hypertension, hyperglycemia, skin changes); review postoperative imaging for residual lesion; note prior treatments and comorbidities.

STEP 2 — Rule In / Rule Out

Is there biochemical evidence of persistent overt hypercortisolism (UFC > upper limit of normal or midnight salivary cortisol > normal) accompanied by compatible clinical features? If YES, proceed to Step 3; if NO, consider eucortisolism or hypocortisolism and manage accordingly (no additional anti‑cortisol therapy indicated).

STEP 3 — Classify or Stratify

Determine ACTH dependence: measure plasma ACTH. If ACTH‑suppressed (<5 pg/mL) → adrenal source; if ACTH‑detectable → ACTH‑dependent (Cushing’s disease or ectopic). For ACTH‑dependent disease, assess surgical feasibility (resectable lesion on MRI) and prior radiation; for adrenal source, evaluate for bilateral adrenal hyperplasia or carcinoma.

STEP 4 — Decide

  • ACTH‑dependent, resectable lesion → recommend repeat transsphenoidal surgery.
  • ACTH‑dependent, not resectable or failed repeat TSS → recommend radiotherapy (conventional or stereotactic) after confirming medical cortisol control, or medical therapy (steroidogenesis inhibitor or receptor antagonist) as bridge.
  • ACTH‑suppressed (adrenal source) → recommend bilateral adrenalectomy if feasible; if not, medical therapy to control cortisol while planning definitive therapy.

Clinical Guardrails / Mimics / Pitfalls

Do not initiate medical therapy as definitive treatment when repeat surgery or radiotherapy is curative and feasible; avoid radiation without prior biochemical control to prevent Nelson syndrome; monitor for hypocortisolism after bilateral adrenalectomy and provide lifelong glucocorticoid/mineralocorticoid replacement; watch for hepatotoxicity with ketoconazole and QT prolongation with pasireotide; do not rely solely on symptoms—biochemical confirmation required.

Concrete Clinical Example

A 45‑year‑old woman 2 months post‑TSS for Cushing’s disease has UFC 350 ng/dL (ULN 145), midnight salivary cortisol 1.2 × ULN, persistent facial plethora and hypertension; MRI shows a 6 mm residual pituitary adenoma. ACTH is detectable. She is a surgical candidate → repeat transsphenoidal surgery is recommended.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., 2015, DOI:10.1210/jc.2015-1818

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

ログインしてレビューを書く

同じリポジトリのスキル

概要と使いどころ

780g-pump-adjustment

無料

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-acth-stim-test-interpretation

無料

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-adrenal-crisis-treatment

無料

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-ai-education

無料

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-lt4-monitoring

無料

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-cortisol-cutoff-ai-diagnosis

無料

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する